Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Sep-24 5:08 PM View:  | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 30-Sep-24 | Grant | 1,342 | $27.92 | $37,475.20 | 2% 58.45K to 59.8K | |
| 30-Sep-24 5:07 PM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 30-Sep-24 | Grant | 1,342 | $27.92 | $37,475.20 | 1% 110.86K to 112.2K | |
| 28-Jun-24 5:09 PM View: | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 28-Jun-24 | Grant | 1,399 | $26.80 | $37,492.90 | 2% 57.05K to 58.45K | |
| 28-Jun-24 5:12 PM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 28-Jun-24 | Grant | 1,399 | $26.80 | $37,492.90 | 1% 109.46K to 110.86K | |
| 10-Jun-24 4:13 PM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 07-Jun-24 | Grant | 9,293 | -- | -- | 9% 100.17K to 109.46K | |
| 10-Jun-24 4:11 PM View: | Desouza Errol B Director | Royalty Pharma Plc (RPRX) | 07-Jun-24 | Grant | 9,293 | -- | -- | 14% 64.44K to 73.74K | |
| 10-Jun-24 4:16 PM View: | Love Ted W Director | Royalty Pharma Plc (RPRX) | 07-Jun-24 | Grant | 9,293 | -- | -- | 25% 36.94K to 46.23K | |
| 10-Jun-24 4:21 PM View: | Norden Gregory Director | Royalty Pharma Plc (RPRX) | 07-Jun-24 | Grant | 9,293 | -- | -- | 14% 64.44K to 73.74K | |
| 10-Jun-24 4:15 PM View: | Hodgson David C Director | Royalty Pharma Plc (RPRX) | 07-Jun-24 | Grant | 9,293 | -- | -- | 57% 16.42K to 25.71K | |
| 10-Jun-24 4:12 PM View: | Engelbert Catherine M. Director | Royalty Pharma Plc (RPRX) | 07-Jun-24 | Grant | 9,293 | -- | -- | 27% 34.22K to 43.51K | |
| 10-Jun-24 4:09 PM View: | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 07-Jun-24 | Grant | 9,293 | -- | -- | 19% 47.76K to 57.05K | |
| 16-May-24 5:42 PM View: | Hite Christopher EVP & Vice Chairman | Royalty Pharma Plc (RPRX) | 13-May-24 | Conversion | 300,000 | -- | -- | 429% 70.0K to 370.0K | |
| 02-Apr-24 5:28 PM View: | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 28-Mar-24 | Grant | 1,240 | $30.23 | $37,483.10 | 3% 46.52K to 47.76K | |
| 02-Apr-24 5:30 PM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 28-Mar-24 | Grant | 1,240 | $30.23 | $37,483.10 | 1% 98.93K to 100.17K | |
| 22-Feb-24 7:23 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 20-Feb-24 | Conversion | 300,000 | -- | -- | 249% 120.29K to 420.29K | |
| 04-Jan-24 5:16 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 04-Jan-24 | Sale | 35,702 | $27.55 | $983,504.00 | (23%) 155.99K to 120.29K | |
| 04-Jan-24 5:16 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 03-Jan-24 | Sale | 199,098 | $27.79 | $5,532,280.00 | (56%) 355.09K to 155.99K | |
| 04-Jan-24 5:16 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 02-Jan-24 | Sale | 235,200 | $28.52 | $6,707,080.00 | (40%) 590.29K to 355.09K | |
| 29-Dec-23 5:11 PM View: | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 29-Dec-23 | Grant | 1,353 | $27.71 | $37,493.00 | 3% 45.17K to 46.52K | |
| 29-Dec-23 5:14 PM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 29-Dec-23 | Grant | 1,353 | $27.71 | $37,493.00 | 1% 97.58K to 98.93K | |
| 03-Jan-24 4:31 PM View: | Avara Management Ltd 10% Owner | Royalty Pharma Plc (RPRX) | 29-Dec-23 | Sale | 65,803 | $28.04 | $1,845,410.00 | (< 1%) 32.62M to 32.56M | |
| 29-Dec-23 4:29 PM View: | Avara Management Ltd 10% Owner | Royalty Pharma Plc (RPRX) | 28-Dec-23 | Sale | 209,863 | $28.20 | $5,918,930.00 | (< 1%) 32.83M to 32.62M | |
| 29-Dec-23 4:29 PM View: | Avara Management Ltd 10% Owner | Royalty Pharma Plc (RPRX) | 27-Dec-23 | Sale | 41,729 | $28.01 | $1,168,750.00 | (< 1%) 32.87M to 32.83M | |
| 19-Dec-23 4:30 PM View: | Avara Management Ltd 10% Owner | Royalty Pharma Plc (RPRX) | 15-Dec-23 | Sale | 10,229 | $28.01 | $286,499.00 | (< 1%) 32.88M to 32.87M | |
| 15-Dec-23 4:31 PM View: | Avara Management Ltd 10% Owner | Royalty Pharma Plc (RPRX) | 14-Dec-23 | Sale | 364,441 | $28.91 | $10,534,300.00 | (1%) 33.25M to 32.88M | |
| 15-Dec-23 4:31 PM View: | Avara Management Ltd 10% Owner | Royalty Pharma Plc (RPRX) | 13-Dec-23 | Sale | 307,935 | $28.95 | $8,916,010.00 | (< 1%) 33.56M to 33.25M | |
| 16-Nov-23 5:50 PM View: | Legorreta Pablo G. CEO, Chairman of the Board Director 10% Owner | Royalty Pharma Plc (RPRX) | 16-Nov-23 | Disposition (other) | 383,000 | -- | -- | (9%) 4.04M to 3.66M | |
| 14-Nov-23 10:00 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 13-Nov-23 | Conversion | 475,590 | -- | -- | 415% 114.7K to 590.29K | |
| 14-Nov-23 7:35 PM View: | Lloyd George W. EVP, Investments & CLO | Royalty Pharma Plc (RPRX) | 13-Nov-23 | Conversion | 150,000 | -- | -- | 16% 926.83K to 1.08M | |
| 03-Oct-23 4:25 PM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 29-Sep-23 | Grant | 1,384 | $27.08 | $37,475.30 | 1% 96.19K to 97.58K | |
| 03-Oct-23 4:23 PM View: | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 29-Sep-23 | Grant | 1,384 | $27.08 | $37,475.30 | 3% 43.78K to 45.17K | |
| 11-Aug-23 5:00 PM View: | Coyne Terrance P. EVP & CFO | Royalty Pharma Plc (RPRX) | 10-Aug-23 | Sale | 37,500 | $30.75 | $1,153,090.00 | (4%) 877.89K to 840.39K | |
| 11-Aug-23 5:00 PM View: | Coyne Terrance P. EVP & CFO | Royalty Pharma Plc (RPRX) | 09-Aug-23 | Sale | 37,500 | $30.72 | $1,151,940.00 | (4%) 915.39K to 877.89K | |
| 14-Jul-23 6:09 PM View: | Coyne Terrance P. EVP & CFO | Royalty Pharma Plc (RPRX) | 13-Jul-23 | Sale | 37,500 | $30.93 | $1,159,960.00 | (4%) 952.89K to 915.39K | |
| 14-Jul-23 6:09 PM View: | Coyne Terrance P. EVP & CFO | Royalty Pharma Plc (RPRX) | 12-Jul-23 | Sale | 37,500 | $31.07 | $1,165,260.00 | (4%) 990.39K to 952.89K | |
| 30-Jun-23 9:12 AM View: | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 30-Jun-23 | Grant | 1,208 | $31.03 | $37,481.00 | 3% 42.58K to 43.78K | |
| 30-Jun-23 9:15 AM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 30-Jun-23 | Grant | 1,208 | $31.03 | $37,481.00 | 1% 94.98K to 96.19K | |
| 28-Jun-23 4:01 PM View: | Legorreta Pablo G. CEO, Chairman of the Board Director 10% Owner | Royalty Pharma Plc (RPRX) | 28-Jun-23 | Purchase | 130,000 | $29.51 | $3,836,770.00 | 4% 3.62M to 3.75M | |
| 26-Jun-23 4:04 PM View: | Desouza Errol B Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 14% 56.7K to 64.44K | |
| 26-Jun-23 4:02 PM View: | Bassler Bonnie L Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 22% 34.83K to 42.58K | |
| 26-Jun-23 4:11 PM View: | Love Ted W Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 27% 29.19K to 36.94K | |
| 26-Jun-23 4:14 PM View: | Riggs Rory B Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 7% 106.95K to 114.7K | |
| 26-Jun-23 4:12 PM View: | Norden Gregory Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 14% 56.7K to 64.44K | |
| 26-Jun-23 4:07 PM View: | Fernandez Henry A Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 9% 87.24K to 94.98K | |
| 26-Jun-23 4:09 PM View: | Hodgson David C Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 89% 8.67K to 16.42K | |
| 26-Jun-23 4:05 PM View: | Engelbert Catherine M. Director | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 30% 25.46K to 33.21K | |
| 27-Jun-23 4:30 PM View: | Giuliani Mario Germano Director 10% Owner | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | < 1% 33.55M to 33.56M | |
| 13-Jun-23 4:01 PM View: | Legorreta Pablo G. CEO, Chairman of the Board Director 10% Owner | Royalty Pharma Plc (RPRX) | 13-Jun-23 | Purchase | 45,000 | $32.78 | $1,474,900.00 | 1% 3.57M to 3.62M | |
| 13-Jun-23 4:01 PM View: | Legorreta Pablo G. CEO, Chairman of the Board Director 10% Owner | Royalty Pharma Plc (RPRX) | 12-Jun-23 | Purchase | 45,000 | $33.00 | $1,484,950.00 | 1% 3.53M to 3.57M | |
| 06-Jun-23 10:00 PM View: | Lloyd George W. EVP, Investments & CLO | Royalty Pharma Plc (RPRX) | 06-Jun-23 | Sale | 79,099 | $33.82 | $2,674,800.00 | (8%) 1.01M to 926.83K |
